Updated on 5/4/2020
Three IPOs and one SPAC are scheduled for the week ahead.
Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
Centogene, which provides genetic tests for rare disease diagnostics and drug development, raised $56 million by offering 4 million shares at $14, the low end of the range of $14 to $16, to command a fully diluted market value of $289 million. Insiders indicated...read more
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more
US IPO Week Ahead: GAN bets on itself in a 3 IPO week
Updated on 5/4/2020 Three IPOs and one SPAC are scheduled for the week ahead. Internet gambling software provider GAN Limited (GAN) plans to raise $48 million at a $224 million fully diluted market cap after ...read more
US IPO Weekly Recap: Small Chinese and healthcare deals price down in an 8-IPO week
Eight small companies and four SPACs entered the public market this past week. Continuing a 4Q trend, all eight deals...read more
Genetic testing provider Centogene prices US IPO at $14 low end
Centogene, which provides genetic tests for rare disease diagnostics and drug development, raised $56 million by offering 4 million shares at $14, the low end of the range of $14 to $16, to command a fully diluted market value of $289 million. Insiders indicated...read more
US IPO Week Ahead: The largest Canadian IPO ever leads a 9-IPO week
In the week ahead, nine IPOs and one SPAC are set to raise $2.6 billion, 75% of which is from GFL Environmental (GFL). GFL is joined by a California bank, three biotechs, two diagnostic/medical device companies, and two Chinese...read more